Požymis
Abnormal speech pattern
An abnormality in the sound (volume) or cadence (rate) of speech.
Santrauka
- Taip pat vadinama
- Abnormal speech, Abnormal vocalisation, Abnormal vocalization, Abnormality of speech or vocalization
- Kūno sistema
- Abnormality of the nervous system
Atskaitos genomasGRCh38hg38
Pozicijos genų ir variantų puslapiuose rodomos pagal šį pasirinkimą šioje naršyklėje.
Read the genes linked to Abnormal speech pattern, and the rest of your genome, with one test.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites
Įsigyti savo Genome Test251 genas susijęs su Abnormal speech pattern
Šių genų pakitimai sukelia retas ligas, kuriose pasireiškia Abnormal speech pattern. Dauguma žmonių, turinčių šį požymį, neturi nė vienos iš tų ligų, o šiame sąraše esantis genas nieko nesako apie kieno nors paties genomą.
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| MN1MN1 proto-oncogene, transcriptional regulator | Visada | 1 ligoje |
| ABCB7ATP binding cassette subfamily B member 7 | Labai dažnai (80–99%) | 1 ligoje |
| ACOX1acyl-CoA oxidase 1 | Labai dažnai (80–99%) | 1 ligoje |
| ADNPactivity dependent neuroprotector homeobox | Labai dažnai (80–99%) | 1 ligoje |
| AGAaspartylglucosaminidase | Labai dažnai (80–99%) | 1 ligoje |
| ARG1arginase 1 | Labai dažnai (80–99%) | 1 ligoje |
| ASXL3ASXL transcriptional regulator 3 | Labai dažnai (80–99%) | 1 ligoje |
| ATMATM serine/threonine kinase | Labai dažnai (80–99%) | 2 ligose |
| ATP1A2ATPase Na+/K+ transporting subunit alpha 2 | Labai dažnai (80–99%) | 1 ligoje |
| B3GALNT2beta-1,3-N-acetylgalactosaminyltransferase 2 | Labai dažnai (80–99%) | 1 ligoje |
| BAZ1Bbromodomain adjacent to zinc finger domain 1B | Labai dažnai (80–99%) | 1 ligoje |
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Labai dažnai (80–99%) | 2 ligose |
| BUD23BUD23 rRNA methyltransferase and ribosome maturation factor | Labai dažnai (80–99%) | 1 ligoje |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Labai dažnai (80–99%) | 1 ligoje |
| CASZ1castor zinc finger 1 | Labai dažnai (80–99%) | 1 ligoje |
| CBLCbl proto-oncogene | Labai dažnai (80–99%) | 1 ligoje |
| CCDC22CCC complex scaffolding subunit CCDC22 | Labai dažnai (80–99%) | 1 ligoje |
| CLIP2CAP-Gly domain containing linker protein 2 | Labai dažnai (80–99%) | 1 ligoje |
| CPT1Acarnitine palmitoyltransferase 1A | Labai dažnai (80–99%) | 1 ligoje |
| CRPPACDP-L-ribitol pyrophosphorylase A | Labai dažnai (80–99%) | 1 ligoje |
| CUL4Bcullin 4B | Labai dažnai (80–99%) | 1 ligoje |
| DDOSTdolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit | Labai dažnai (80–99%) | 1 ligoje |
| DNAJC30DnaJ heat shock protein family (Hsp40) member C30 | Labai dažnai (80–99%) | 1 ligoje |
| DPYSL5dihydropyrimidinase like 5 | Labai dažnai (80–99%) | 1 ligoje |
| EIF4Heukaryotic translation initiation factor 4H | Labai dažnai (80–99%) | 1 ligoje |
| ELNelastin | Labai dažnai (80–99%) | 1 ligoje |
| ELOVL4ELOVL fatty acid elongase 4 | Labai dažnai (80–99%) | 1 ligoje |
| FKBP6FKBP prolyl isomerase family member 6 (inactive) | Labai dažnai (80–99%) | 1 ligoje |
| FKRPfukutin related protein | Labai dažnai (80–99%) | 1 ligoje |
| FKTNfukutin | Labai dažnai (80–99%) | 1 ligoje |
| FMR1fragile X messenger ribonucleoprotein 1 | Labai dažnai (80–99%) | 1 ligoje |
| FOXP2forkhead box P2 | Labai dažnai (80–99%) | 2 ligose |
| GABRDgamma-aminobutyric acid type A receptor subunit delta | Labai dažnai (80–99%) | 1 ligoje |
| GATA2GATA binding protein 2 | Labai dažnai (80–99%) | 1 ligoje |
| GDF5growth differentiation factor 5 | Labai dažnai (80–99%) | 1 ligoje |
| GMPPBGDP-mannose pyrophosphorylase B | Labai dažnai (80–99%) | 1 ligoje |
| GTF2Igeneral transcription factor IIi | Labai dažnai (80–99%) | 1 ligoje |
| GTF2IRD1GTF2I repeat domain containing 1 | Labai dažnai (80–99%) | 1 ligoje |
| GTF2IRD2GTF2I repeat domain containing 2 | Labai dažnai (80–99%) | 1 ligoje |
| HBA1hemoglobin subunit alpha 1 | Labai dažnai (80–99%) | 1 ligoje |
Rodyti dar 211 genų
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| HBA2hemoglobin subunit alpha 2 | Labai dažnai (80–99%) | 1 ligoje |
| HSPG2heparan sulfate proteoglycan 2 | Labai dažnai (80–99%) | 2 ligose |
| KCNAB2potassium voltage-gated channel subfamily A regulatory beta subunit 2 | Labai dažnai (80–99%) | 1 ligoje |
| KRASKRas proto-oncogene, GTPase | Labai dažnai (80–99%) | 4 ligose |
| LARGE1LARGE xylosyl- and glucuronyltransferase 1 | Labai dažnai (80–99%) | 1 ligoje |
| LIMK1LIM domain kinase 1 | Labai dažnai (80–99%) | 1 ligoje |
| LUZP1leucine zipper protein 1 | Labai dažnai (80–99%) | 1 ligoje |
| LZTR1leucine zipper like post translational regulator 1 | Labai dažnai (80–99%) | 1 ligoje |
| MAP2K1mitogen-activated protein kinase kinase 1 | Labai dažnai (80–99%) | 1 ligoje |
| MAP2K2mitogen-activated protein kinase kinase 2 | Labai dažnai (80–99%) | 1 ligoje |
| MAPTmicrotubule associated protein tau | Labai dažnai (80–99%) | 3 ligose |
| MECP2methyl-CpG binding protein 2 | Labai dažnai (80–99%) | 1 ligoje |
| MED12mediator complex subunit 12 | Labai dažnai (80–99%) | 1 ligoje |
| METTL27methyltransferase like 27 | Labai dažnai (80–99%) | 1 ligoje |
| MMP23Bmatrix metallopeptidase 23B | Labai dažnai (80–99%) | 1 ligoje |
| MRASmuscle RAS oncogene homolog | Labai dažnai (80–99%) | 1 ligoje |
| NCF1neutrophil cytosolic factor 1 | Labai dažnai (80–99%) | 1 ligoje |
| NEU1neuraminidase 1 | Labai dažnai (80–99%) | 1 ligoje |
| NOTCH2NLCnotch 2 N-terminal like C | Labai dažnai (80–99%) | 1 ligoje |
| NRASNRAS proto-oncogene, GTPase | Labai dažnai (80–99%) | 1 ligoje |
| ORAI1ORAI calcium release-activated calcium modulator 1 | Labai dažnai (80–99%) | 1 ligoje |
| PDPNpodoplanin | Labai dažnai (80–99%) | 1 ligoje |
| PNPLA6patatin like domain 6, lysophospholipase | Labai dažnai (80–99%) | 1 ligoje |
| POMGNT1protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-) | Labai dažnai (80–99%) | 1 ligoje |
| POMT1protein O-mannosyltransferase 1 | Labai dažnai (80–99%) | 1 ligoje |
| POMT2protein O-mannosyltransferase 2 | Labai dažnai (80–99%) | 1 ligoje |
| PRDM16PR/SET domain 16 | Labai dažnai (80–99%) | 1 ligoje |
| PRKCZprotein kinase C zeta | Labai dažnai (80–99%) | 1 ligoje |
| PRRT2proline rich transmembrane protein 2 | Labai dažnai (80–99%) | 2 ligose |
| PTPN11protein tyrosine phosphatase non-receptor type 11 | Labai dažnai (80–99%) | 1 ligoje |
| RAB39BRAB39B, member RAS oncogene family | Labai dažnai (80–99%) | 1 ligoje |
| RAF1Raf-1 proto-oncogene, serine/threonine kinase | Labai dažnai (80–99%) | 1 ligoje |
| RAI1retinoic acid induced 1 | Labai dažnai (80–99%) | 1 ligoje |
| RASA2RAS p21 protein activator 2 | Labai dažnai (80–99%) | 1 ligoje |
| REREarginine-glutamic acid dipeptide repeats | Labai dažnai (80–99%) | 1 ligoje |
| RFC2replication factor C subunit 2 | Labai dažnai (80–99%) | 1 ligoje |
| RIT1Ras like without CAAX 1 | Labai dažnai (80–99%) | 1 ligoje |
| RNF216ring finger protein 216 | Labai dažnai (80–99%) | 1 ligoje |
| RPS6KA3ribosomal protein S6 kinase A3 | Labai dažnai (80–99%) | 1 ligoje |
| RRASRAS related | Labai dažnai (80–99%) | 1 ligoje |
| RRAS2RAS related 2 | Labai dažnai (80–99%) | 1 ligoje |
| SCN1Asodium voltage-gated channel alpha subunit 1 | Labai dažnai (80–99%) | 1 ligoje |
| SIL1SIL1 nucleotide exchange factor | Labai dažnai (80–99%) | 1 ligoje |
| SKISKI proto-oncogene | Labai dažnai (80–99%) | 1 ligoje |
| SOS1SOS Ras/Rac guanine nucleotide exchange factor 1 | Labai dažnai (80–99%) | 1 ligoje |
| SOS2SOS Ras/Rho guanine nucleotide exchange factor 2 | Labai dažnai (80–99%) | 1 ligoje |
| SPENspen family transcriptional repressor | Labai dažnai (80–99%) | 1 ligoje |
| SPRED2sprouty related EVH1 domain containing 2 | Labai dažnai (80–99%) | 1 ligoje |
| STIM1stromal interaction molecule 1 | Labai dažnai (80–99%) | 1 ligoje |
| STX1Asyntaxin 1A | Labai dažnai (80–99%) | 1 ligoje |
| TBL2transducin beta like 2 | Labai dažnai (80–99%) | 1 ligoje |
| TIMM50translocase of inner mitochondrial membrane 50 | Labai dažnai (80–99%) | 1 ligoje |
| TMEM270transmembrane protein 270 | Labai dažnai (80–99%) | 1 ligoje |
| UBE4Bubiquitination factor E4B | Labai dažnai (80–99%) | 1 ligoje |
| UPF3BUPF3B regulator of nonsense mediated mRNA decay | Labai dažnai (80–99%) | 1 ligoje |
| VPS13Bvacuolar protein sorting 13 homolog B | Labai dažnai (80–99%) | 1 ligoje |
| VPS35LVPS35 endosomal protein sorting factor like | Labai dažnai (80–99%) | 1 ligoje |
| VPS37DVPS37D subunit of ESCRT-I | Labai dažnai (80–99%) | 1 ligoje |
| WASHC5WASH complex subunit 5 | Labai dažnai (80–99%) | 1 ligoje |
| ZC4H2zinc finger C4H2-type containing | Labai dažnai (80–99%) | 1 ligoje |
| ZDHHC9zDHHC palmitoyltransferase 9 | Labai dažnai (80–99%) | 1 ligoje |
| ADARadenosine deaminase RNA specific | Dažnai (30–79%) | 1 ligoje |
| ALS2alsin Rho guanine nucleotide exchange factor ALS2 | Dažnai (30–79%) | 2 ligose |
| ATP13A2ATPase cation transporting 13A2 | Dažnai (30–79%) | 1 ligoje |
| BRD4bromodomain containing 4 | Dažnai (30–79%) | 1 ligoje |
| CCDC88Ccoiled-coil and HOOK domain protein 88C | Dažnai (30–79%) | 1 ligoje |
| CHMP2Bcharged multivesicular body protein 2B | Dažnai (30–79%) | 1 ligoje |
| CLN8CLN8 transmembrane ER and ERGIC protein | Dažnai (30–79%) | 1 ligoje |
| DAB1DAB adaptor protein 1 | Dažnai (30–79%) | 1 ligoje |
| DARS2aspartyl-tRNA synthetase 2, mitochondrial | Dažnai (30–79%) | 1 ligoje |
| ERLIN1ER lipid raft associated 1 | Dažnai (30–79%) | 1 ligoje |
| FGFR1fibroblast growth factor receptor 1 | Dažnai (30–79%) | 1 ligoje |
| FUSFUS RNA binding protein | Dažnai (30–79%) | 1 ligoje |
| GNEglucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | Dažnai (30–79%) | 1 ligoje |
| GPC3glypican 3 | Dažnai (30–79%) | 1 ligoje |
| GPC4glypican 4 | Dažnai (30–79%) | 1 ligoje |
| GRID2glutamate ionotropic receptor delta type subunit 2 | Dažnai (30–79%) | 1 ligoje |
| GRM1glutamate metabotropic receptor 1 | Dažnai (30–79%) | 1 ligoje |
| GRNgranulin precursor | Dažnai (30–79%) | 1 ligoje |
| HDAC8histone deacetylase 8 | Dažnai (30–79%) | 1 ligoje |
| ITPR1inositol 1,4,5-trisphosphate receptor type 1 | Dažnai (30–79%) | 1 ligoje |
| MAU2MAU2 sister chromatid cohesion factor | Dažnai (30–79%) | 1 ligoje |
| MT-ATP6mitochondrially encoded ATP synthase membrane subunit 6 | Dažnai (30–79%) | 1 ligoje |
| MTORmechanistic target of rapamycin kinase | Dažnai (30–79%) | 1 ligoje |
| MTRR5-methyltetrahydrofolate-homocysteine methyltransferase reductase | Dažnai (30–79%) | 1 ligoje |
| MYH3myosin heavy chain 3 | Dažnai (30–79%) | 1 ligoje |
| NALCNsodium leak channel, non-selective | Dažnai (30–79%) | 1 ligoje |
| NECTIN1nectin cell adhesion molecule 1 | Dažnai (30–79%) | 1 ligoje |
| NIPBLNIPBL cohesin loading factor | Dažnai (30–79%) | 1 ligoje |
| NUP54nucleoporin 54 | Dažnai (30–79%) | 1 ligoje |
| NUP62nucleoporin 62 | Dažnai (30–79%) | 1 ligoje |
| OCA2OCA2 melanosomal transmembrane protein | Dažnai (30–79%) | 1 ligoje |
| OPHN1oligophrenin 1 | Dažnai (30–79%) | 1 ligoje |
| PAX6paired box 6 | Dažnai (30–79%) | 1 ligoje |
| PIK3R1phosphoinositide-3-kinase regulatory subunit 1 | Dažnai (30–79%) | 1 ligoje |
| PLP1proteolipid protein 1 | Dažnai (30–79%) | 2 ligose |
| PSEN1presenilin 1 | Dažnai (30–79%) | 1 ligoje |
| RAD21RAD21 cohesin complex component | Dažnai (30–79%) | 1 ligoje |
| SAMD9Lsterile alpha motif domain containing 9 like | Dažnai (30–79%) | 1 ligoje |
| SIGMAR1sigma receptor chaperone 1 | Dažnai (30–79%) | 1 ligoje |
| SMC1Astructural maintenance of chromosomes 1A | Dažnai (30–79%) | 1 ligoje |
| SMC3structural maintenance of chromosomes 3 | Dažnai (30–79%) | 1 ligoje |
| SORDsorbitol dehydrogenase | Dažnai (30–79%) | 1 ligoje |
| SPG11SPG11 vesicle trafficking associated, spatacsin | Dažnai (30–79%) | 1 ligoje |
| SPTLC1serine palmitoyltransferase long chain base subunit 1 | Dažnai (30–79%) | 1 ligoje |
| SPTLC2serine palmitoyltransferase long chain base subunit 2 | Dažnai (30–79%) | 1 ligoje |
| SYNE1spectrin repeat containing nuclear envelope protein 1 | Dažnai (30–79%) | 1 ligoje |
| TARDBPTAR DNA binding protein | Dažnai (30–79%) | 1 ligoje |
| TBK1TANK binding kinase 1 | Dažnai (30–79%) | 1 ligoje |
| TBX1T-box transcription factor 1 | Dažnai (30–79%) | 1 ligoje |
| TFAP2Atranscription factor AP-2 alpha | Dažnai (30–79%) | 1 ligoje |
| TICAM1TIR domain containing adaptor molecule 1 | Dažnai (30–79%) | 1 ligoje |
| TLR3toll like receptor 3 | Dažnai (30–79%) | 1 ligoje |
| TMEM106Btransmembrane protein 106B | Dažnai (30–79%) | 1 ligoje |
| TRAF3TNF receptor associated factor 3 | Dažnai (30–79%) | 1 ligoje |
| TRANK1tetratricopeptide repeat and ankyrin repeat containing 1 | Dažnai (30–79%) | 1 ligoje |
| TREM2triggering receptor expressed on myeloid cells 2 | Dažnai (30–79%) | 3 ligose |
| TRMT2BtRNA methyltransferase 2B | Dažnai (30–79%) | 1 ligoje |
| TTPAalpha tocopherol transfer protein | Dažnai (30–79%) | 1 ligoje |
| TYROBPtransmembrane immune signaling adaptor TYROBP | Dažnai (30–79%) | 2 ligose |
| UBE3Aubiquitin protein ligase E3A | Dažnai (30–79%) | 3 ligose |
| UBQLN2ubiquilin 2 | Dažnai (30–79%) | 1 ligoje |
| UNC93B1unc-93B1 regulator of TLR signaling | Dažnai (30–79%) | 1 ligoje |
| WARS2tryptophanyl tRNA synthetase 2, mitochondrial | Dažnai (30–79%) | 2 ligose |
| ABCD1ATP binding cassette subfamily D member 1 | Kartais (5–29%) | 1 ligoje |
| ARL6ARF like GTPase 6 | Kartais (5–29%) | 2 ligose |
| BBIP1BBSome interacting protein 1 | Kartais (5–29%) | 1 ligoje |
| BBS1Bardet-Biedl syndrome 1 | Kartais (5–29%) | 2 ligose |
| BBS10Bardet-Biedl syndrome 10 | Kartais (5–29%) | 1 ligoje |
| BBS12Bardet-Biedl syndrome 12 | Kartais (5–29%) | 1 ligoje |
| BBS2Bardet-Biedl syndrome 2 | Kartais (5–29%) | 1 ligoje |
| BBS4Bardet-Biedl syndrome 4 | Kartais (5–29%) | 1 ligoje |
| BBS5Bardet-Biedl syndrome 5 | Kartais (5–29%) | 1 ligoje |
| BBS7Bardet-Biedl syndrome 7 | Kartais (5–29%) | 1 ligoje |
| BBS9Bardet-Biedl syndrome 9 | Kartais (5–29%) | 1 ligoje |
| BCORBCL6 corepressor | Kartais (5–29%) | 1 ligoje |
| BMPR1Abone morphogenetic protein receptor type 1A | Kartais (5–29%) | 1 ligoje |
| BRCA2BRCA2 DNA repair associated | Kartais (5–29%) | 1 ligoje |
| CEP19centrosomal protein 19 | Kartais (5–29%) | 1 ligoje |
| CEP290centrosomal protein 290 | Kartais (5–29%) | 1 ligoje |
| CFAP418cilia and flagella associated protein 418 | Kartais (5–29%) | 1 ligoje |
| CHEK2checkpoint kinase 2 | Kartais (5–29%) | 1 ligoje |
| CXCR4C-X-C motif chemokine receptor 4 | Kartais (5–29%) | 1 ligoje |
| EPCAMepithelial cell adhesion molecule | Kartais (5–29%) | 1 ligoje |
| FLGfilaggrin | Kartais (5–29%) | 1 ligoje |
| FOXI1forkhead box I1 | Kartais (5–29%) | 1 ligoje |
| HLA-Bmajor histocompatibility complex, class I, B | Kartais (5–29%) | 1 ligoje |
| IFT172intraflagellar transport 172 | Kartais (5–29%) | 1 ligoje |
| IFT27intraflagellar transport 27 | Kartais (5–29%) | 1 ligoje |
| IFT74intraflagellar transport 74 | Kartais (5–29%) | 1 ligoje |
| IL12Binterleukin 12B | Kartais (5–29%) | 1 ligoje |
| KCNJ10potassium inwardly rectifying channel subfamily J member 10 | Kartais (5–29%) | 1 ligoje |
| LPIN1lipin 1 | Kartais (5–29%) | 1 ligoje |
| LZTFL1leucine zipper transcription factor like 1 | Kartais (5–29%) | 1 ligoje |
| MKKSMKKS centrosomal shuttling protein | Kartais (5–29%) | 1 ligoje |
| MKS1MKS transition zone complex subunit 1 | Kartais (5–29%) | 1 ligoje |
| MLH1mutL homolog 1 | Kartais (5–29%) | 1 ligoje |
| MLXMAX dimerization protein MLX | Kartais (5–29%) | 1 ligoje |
| MMACHCmetabolism of cobalamin associated C | Kartais (5–29%) | 1 ligoje |
| MORC2MORC family CW-type zinc finger 2 | Kartais (5–29%) | 1 ligoje |
| MSH2mutS homolog 2 | Kartais (5–29%) | 1 ligoje |
| MSH6mutS homolog 6 | Kartais (5–29%) | 1 ligoje |
| MT-CO1mitochondrially encoded cytochrome c oxidase I | Kartais (5–29%) | 1 ligoje |
| MT-CO3mitochondrially encoded cytochrome c oxidase III | Kartais (5–29%) | 1 ligoje |
| MUTYHmutY DNA glycosylase | Kartais (5–29%) | 1 ligoje |
| NAA10N-alpha-acetyltransferase 10, NatA catalytic subunit | Kartais (5–29%) | 1 ligoje |
| NPATnuclear protein, coactivator of histone transcription | Kartais (5–29%) | 1 ligoje |
| NPHP1nephrocystin 1 | Kartais (5–29%) | 1 ligoje |
| OBSCNobscurin, cytoskeletal calmodulin and titin-interacting RhoGEF | Kartais (5–29%) | 1 ligoje |
| PANK2pantothenate kinase 2 | Kartais (5–29%) | 1 ligoje |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Kartais (5–29%) | 2 ligose |
| PMS1PMS1 homolog 1, mismatch repair system component | Kartais (5–29%) | 1 ligoje |
| PMS2PMS1 homolog 2, mismatch repair system component | Kartais (5–29%) | 1 ligoje |
| PNKDPNKD metallo-beta-lactamase domain containing | Kartais (5–29%) | 1 ligoje |
| POLD1DNA polymerase delta 1, catalytic subunit | Kartais (5–29%) | 1 ligoje |
| POLEDNA polymerase epsilon, catalytic subunit | Kartais (5–29%) | 1 ligoje |
| PTENphosphatase and tensin homolog | Kartais (5–29%) | 1 ligoje |
| RPS20ribosomal protein S20 | Kartais (5–29%) | 1 ligoje |
| SCAPERS-phase cyclin A associated protein in the ER | Kartais (5–29%) | 1 ligoje |
| SCLT1sodium channel and clathrin linker 1 | Kartais (5–29%) | 1 ligoje |
| SDCCAG8SHH signaling and ciliogenesis regulator SDCCAG8 | Kartais (5–29%) | 1 ligoje |
| SEMA4Asemaphorin 4A | Kartais (5–29%) | 1 ligoje |
| SEPTIN9septin 9 | Kartais (5–29%) | 1 ligoje |
| SLC26A4solute carrier family 26 member 4 | Kartais (5–29%) | 1 ligoje |
| STSsteroid sulfatase | Kartais (5–29%) | 1 ligoje |
| STUB1STIP1 homology and U-box containing protein 1 | Kartais (5–29%) | 1 ligoje |
| TATtyrosine aminotransferase | Kartais (5–29%) | 1 ligoje |
| TBXAS1thromboxane A synthase 1 | Kartais (5–29%) | 1 ligoje |
| TGFB1transforming growth factor beta 1 | Kartais (5–29%) | 1 ligoje |
| TGFBR2transforming growth factor beta receptor 2 | Kartais (5–29%) | 1 ligoje |
| TRIM32tripartite motif containing 32 | Kartais (5–29%) | 1 ligoje |
| TTC8tetratricopeptide repeat domain 8 | Kartais (5–29%) | 1 ligoje |
| WDPCPWD repeat containing planar cell polarity effector | Kartais (5–29%) | 1 ligoje |
| AKT1AKT serine/threonine kinase 1 | Retai (1–4 %) | 1 ligoje |
| BAP1BRCA1 associated deubiquitinase 1 | Retai (1–4 %) | 1 ligoje |
| HALhistidine ammonia-lyase | Retai (1–4 %) | 1 ligoje |
| NF2NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor | Retai (1–4 %) | 1 ligoje |
| PDGFBplatelet derived growth factor subunit B | Retai (1–4 %) | 1 ligoje |
| SMARCB1SWI/SNF related BAF chromatin remodeling complex subunit B1 | Retai (1–4 %) | 1 ligoje |
| SMARCE1SWI/SNF related BAF chromatin remodeling complex subunit E1 | Retai (1–4 %) | 1 ligoje |
| SMOsmoothened, frizzled class receptor | Retai (1–4 %) | 1 ligoje |
| SPTBN1spectrin beta, non-erythrocytic 1 | Retai (1–4 %) | 1 ligoje |
| SUFUSUFU negative regulator of hedgehog signaling | Retai (1–4 %) | 1 ligoje |
| TERTtelomerase reverse transcriptase | Retai (1–4 %) | 1 ligoje |
| TRAF7TNF receptor associated factor 7 | Retai (1–4 %) | 1 ligoje |
| CCDC28Bcoiled-coil domain containing 28B | Neužfiksuota | 1 ligoje |
| DNAAF4dynein axonemal assembly factor 4 | Neužfiksuota | 1 ligoje |
| FHfumarate hydratase | Neužfiksuota | 1 ligoje |
| GBA1glucosylceramidase beta 1 | Neužfiksuota | 1 ligoje |
| MANBAmannosidase beta | Neužfiksuota | 1 ligoje |
| UPB1beta-ureidopropionase 1 | Neužfiksuota | 1 ligoje |
Kaip dažnai šis požymis pasitaiko žmonėms, turintiems vieną iš geno sukeliamų ligų, ir kuris dažnis tarp jų didžiausias, pagal Žmogaus fenotipo ontologijos duomenis. Šiuose puslapiuose aprašomi požymiai ir juos grindžiantys tyrimai; tai nėra diagnozė, o su simptomais kreipkitės į gydytoją ar genetikos konsultantą.
Siauresni požymiai
- Delayed speech and language development983 genų
- Difficulty articulating speech601 genas
- Poor speech198 genų
- Difficulty finding words95 genų
- Dysgraphia54 genų
- Inability to speak52 genų
- Loss of speech46 genų
- Loss of articulate speech26 genų
- Stuttering25 genų
- Explosive speech16 genų
- Abnormal prosody15 genų
- Incomprehensible speech8 genų
- Text blindness7 genų
- Abnormal speech rate
Platesni požymiai
Iš kur tai žinoma
- Žmogaus fenotipo ontologija, 2026-09-01 leidimas: požymis, jo pavadinimai, apibrėžimas ir su juo susiję genai. Daugiau sužinokite svetainėje hpo.jax.org.
- Duomenų leidimas 2026.10.16-c6eea6bf.
Vienas testas. Atsakymai visam gyvenimui.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites